Background/Objectives: Breast cancer (BC) is the most frequently diagnosed malignancy and a leading cause of cancer-related mortality in women worldwide. This disease is highly heterogeneous and dynamic, and chromosomal instability (CIN) plays a key role in the acquisition of these traits by generating genetic diversity that promotes tumor adaptation and influences therapeutic response and prognosis. Although several methods have been developed to quantify CIN, they are not readily applicable to human tumors and are limited in resolution, hindering a comprehensive understanding of intratumoral heterogeneity. In this study, we aimed to quantify CIN levels and clonal heterogeneity (CH) in HER2-positive (HER2+) and triple-negative (TNBC) breast cancer using single-cell RNA sequencing (scRNA-seq) data. Methods: We analyzed publicly available scRNA-seq data from HER2+ and TNBC tumors and non-malignant controls. CIN was scored at single-cell resolution using transcriptomic signatures, clonal heterogeneity was estimated from single-cell diversity metrics, and copy number alterations were inferred computationally. Differential expression and functional enrichment analyses were performed between cells with very low and extreme CIN levels, with key comparisons confirmed at the patient level. Results: Our analyses revealed pronounced intra- and intertumoral heterogeneity, with higher CIN levels in TNBC than in HER2+ and control samples. Genes differentially expressed in cells with extreme CIN values were mainly involved in cell division and related processes, and included candidate biomarkers not previously reported in this context. Our findings suggest a positive but statistically non-significant trend was observed between CIN and CH. Conclusions: Single-cell approaches such as scRNA-seq provide a powerful framework to elucidate CIN-related mechanisms and to identify potential biomarkers of BC aggressiveness and prognosis, supporting their further application in the study of intratumoral heterogeneity.
María Paula Meléndez-Flórez, N. Rangel, Milena Rondón-Lagos et al.· Biomedicines· 0 citations
Many fish undergo dramatic, socially cued female-to-male sex change, yet the events that initiate and then regulate gonadal reprogramming and reorganisation during this phenomenal metamorphosis are broadly unknown. The New Zealand spotted wrasse, Notolabrus celidotus, is a temperate fish species that displays the extraordinary ability to undergo protogynous sex change. Removal of a terminal-phase male from a social group triggers the most dominant female to change sex and become a male. To characterise the molecular changes associated with gonadal metamorphosis in spotty, we used genomic and transcriptomic approaches, generating a high-quality genome and a transcriptomic time-series that captures the sex change process from start to finish. These data, together with paired histological data, reveal distinct transcriptional profiles that characterise the process of sex change. As expected, the expression of masculinising genes steadily increases, while feminising genes steadily decrease, throughout the transition. We further identify novel candidate genes, including genes involved in immune signalling and tissue remodelling through inflammation-mediated apoptosis, whose expression strongly correlates with key events in sex change, while also confirming the roles of known sex determination and differentiation genes in this process. Collectively these data give us new insights into how a normally committed developmental process remains plastic and is reversed to completely alter organ structures, and also sheds light on the evolution of sex determination in other animals. This work furthers the development of the spotty as a new tractable model for sex change research.
Chloé A. van der Burg, A. Goikoetxea, S. Muncaster et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.